Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Researchers describe three cleaning procedures that effectively remove, disassemble α-Syn fibrils

Lewy bodies and Lewy neurites are found in the brains of Parkinson's disease (PD) patients. They consist primarily of fibrils of the protein alpha-synuclein (α-Syn), which self-assembles into fibrils in vitro. If introduced into the human body, these seeds can act as prions and trigger the formation of toxic protein deposits. Because α-Syn fibrils are often used in research, it is important that they are not accidentally transferred to humans or cell cultures.

11 Jan 2016

UTA researchers map out chemical mechanism of key enzyme found in autism, Alzheimer's and Down syndrome

Biochemists at The University of Texas at Arlington are mapping the catalytic processes of sulfur-oxidizing enzymes to improve understanding of the chemical imbalances found in patients with autism, Alzheimer's disease and Down syndrome.

11 Jan 2016

Promising novel approach to treat gynecologic tumors

UCLA scientists have developed a promising novel method to treat gynecologic tumors. The approach focuses on a protein called p53, which is commonly mutated in women who have high-grade serous ovarian cancer, the deadliest form of reproductive cancer. In many women with the disease, the cancer is very advanced by the time it is diagnosed and is therefore difficult to treat.

7 Jan 2016

Alpha-synuclein protein involved in Parkinson's disease pathology does not behave like a 'prion'

In Parkinson's disease, the protein "alpha-synuclein" aggregates within neurons of patients and appears to propagate across interconnected areas of the brain. How this happens remains largely unknown.

6 Jan 2016

Anticholinergic medications do not affect cognitive performance in PD patients

Recent evidence has shown a greater risk of dementia, in particular Alzheimer's disease (AD), in individuals using anticholinergic medications regularly. These drugs are widely used by older adults to treat bladder dysfunction, mood, and pain, and many of them are available without prescription.

5 Jan 2016

New study outlines risk for in-hospital and out-of-hospital births in Oregon

The out-of-hospital birth setting in Oregon was associated with a higher risk of perinatal death, while the in-hospital birth setting was associated with a higher risk for cesarean delivery and other obstetric interventions (e.g., induction or augmentation of labor), according a study published today in the New England Journal of Medicine by researchers at Oregon Health & Science University.

31 Dec 2015

UW-led effort aims to develop implantable devices that promote brain plasticity, reanimate paralyzed limbs

In the next decade, people who have suffered a spinal cord injury or stroke could have their mobility improved or even restored through a radically new technology: implantable devices that can send signals between regions of the brain or nervous system that have been disconnected due to injury.

30 Dec 2015

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

Amarantus BioScience Holdings, Inc., a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the US Food and Drug Administration to treat GCMN with Engineered Skin Substitute (ESS).

30 Dec 2015

TweetChat on AAN's guideline for diagnosing and treating sports concussions

As the nation expands its conversation about sports concussion this week, the American Academy of Neurology, the world's most trusted authority on concussion, will host a TweetChat at 1 p.m. ET, Monday, December 28, to help educate parents, coaches and athletes about the AAN's guideline for diagnosing and treating sports concussion.

24 Dec 2015

Hepatitis C virus linked to increased risk of developing Parkinson's disease

The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the December 23, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology.

24 Dec 2015

Opicapone simplifies levodopa-related motor fluctuation treatment

Once-daily opicapone is effective for the treatment of end-of-dose motor fluctuations in patients receiving levodopa for Parkinson’s disease, phase III study findings show.

23 Dec 2015

‘Gunslinger’s gait’ should be included in differential diagnosis

An analysis of the gait of top Russian officials has led researchers to warn neurologists against interpreting a probable behavioural adaptation as a pathological gait pattern.

23 Dec 2015

Bern study sheds light on the brain mechanism of arousal

Scientists from Bern have discovered a mechanism which is responsible for the rapid arousal from sleep and anesthesia in the brain. The results of their study suggest new strategies for the medical treatment of sleep disorders and recovery of consciousness in vegetative states.

22 Dec 2015

Benjamin Wolozin receives $500,000 award in Alzheimer's Disease Drug Discovery Research

Research that leads to improved therapies for Alzheimer's disease (AD) patients is one goal of Boston University School of Medicine professor of pharmacology and neurology Benjamin Wolozin, MD, PhD. He was one of six researchers awarded a two-year, $500,000 award in Alzheimer's Disease Drug Discovery Research by the Edward N. & Della L. Thome Memorial Foundation.

22 Dec 2015

Novel drug candidate prevents nerve cell damage in mouse model of Parkinson's disease

A team of scientists at the University of Nebraska Medical Center (UNMC) and Longevity Biotech, Inc., has demonstrated that neuroprotection could be attained in preclinical models by a novel drug candidate that changes immune responses.

18 Dec 2015

UA developing brain-scanning technology that could improve diagnosis of many disorders

Researchers at the University of Arizona are developing a noninvasive brain-scanning technology that could produce images far superior to those obtained with the most commonly used systems -- electroencephalography and functional magnetic resonance imaging.

17 Dec 2015

Epilepsy deaths should be considered a public health priority, say doctors

Epilepsy is not a public health priority, yet it takes more lives than sudden infant death syndrome (SIDS) or fires, according to an article reviewing the topic. Doctors say epilepsy deaths should be a focus of research and education to understand and prevent those deaths, according to the "Views and Reviews" article published in the December 16, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

17 Dec 2015

Designing epidemiologic study for multiple sclerosis and other neurologic diseases in Gulf War Vets

The U.S. Department of Veterans Affairs requested that the National Academies of Sciences, Engineering, and Medicine conduct a study to respond to Public Law 110-389 to determine the incidence, prevalence, and risk of developing multiple sclerosis and other neurologic diseases -- including migraines, Parkinson's disease, brain cancers, and central nervous system abnormalities difficult to diagnose precisely -- as a result of service in the 1990-1991 Persian Gulf and post 9/11 Global Operations theaters.

12 Dec 2015

TSRI-led study shows how different drugs regulate protein linked to asthma, obesity and diabetes

A new study, led by scientists at The Scripps Research Institute, shows how different pharmaceutical drugs hit either the "on" or "off" switch of a signaling protein linked to asthma, obesity and type 2 diabetes.

11 Dec 2015

Apigenin improves neuron formation, strengthens connections between brain cells

Brazilian researchers from D'Or Institute for Research and Education, Federal University of Rio de Janeiro and Federal University of Bahia have demonstrated in laboratory that apigenin, a substance found in parsley, thyme, chamomile and red pepper, improves neuron formation and strengthens the connections between brain cells.

11 Dec 2015

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Researchers describe three cleaning procedures that effectively remove, disassemble α-Syn fibrils

UTA researchers map out chemical mechanism of key enzyme found in autism, Alzheimer's and Down syndrome

Promising novel approach to treat gynecologic tumors

Alpha-synuclein protein involved in Parkinson's disease pathology does not behave like a 'prion'

Anticholinergic medications do not affect cognitive performance in PD patients

New study outlines risk for in-hospital and out-of-hospital births in Oregon

UW-led effort aims to develop implantable devices that promote brain plasticity, reanimate paralyzed limbs

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

TweetChat on AAN's guideline for diagnosing and treating sports concussions

Hepatitis C virus linked to increased risk of developing Parkinson's disease

Opicapone simplifies levodopa-related motor fluctuation treatment

‘Gunslinger’s gait’ should be included in differential diagnosis

Bern study sheds light on the brain mechanism of arousal

Benjamin Wolozin receives $500,000 award in Alzheimer's Disease Drug Discovery Research

Novel drug candidate prevents nerve cell damage in mouse model of Parkinson's disease

UA developing brain-scanning technology that could improve diagnosis of many disorders

Epilepsy deaths should be considered a public health priority, say doctors

Designing epidemiologic study for multiple sclerosis and other neurologic diseases in Gulf War Vets

TSRI-led study shows how different drugs regulate protein linked to asthma, obesity and diabetes

Apigenin improves neuron formation, strengthens connections between brain cells

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in